These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19838499)

  • 1. Percutaneous coronary intervention for stable patients: is there any benefit beyond symptom relief?
    Stankovic G
    Arq Bras Cardiol; 2009 Aug; 93(2):196-9. PubMed ID: 19838499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention for chronic stable angina: a reassessment.
    Holmes DR; Gersh BJ; Whitlow P; King SB; Dove JT
    JACC Cardiovasc Interv; 2008 Feb; 1(1):34-43. PubMed ID: 19393142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COURAGE trial in perspective.
    Prasad A; Rihal C; Holmes DR
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):54-9. PubMed ID: 18412271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina.
    Latib A; Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent changes in practice of elective percutaneous coronary intervention for stable angina.
    Ahmed B; Dauerman HL; Piper WD; Robb JF; Verlee MP; Ryan TJ; Goldberg D; Boss RA; Phillips WJ; Fedele F; Butzel D; Malenka DJ;
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):300-5. PubMed ID: 21505155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
    Pursnani S; Korley F; Gopaul R; Kanade P; Chandra N; Shaw RE; Bangalore S
    Circ Cardiovasc Interv; 2012 Aug; 5(4):476-90. PubMed ID: 22872053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
    Boden WE
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.
    Stergiopoulos K; Brown DL
    Arch Intern Med; 2012 Feb; 172(4):312-9. PubMed ID: 22371919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategy for patients with low-risk coronary artery disease: initial medical therapy only or PCI plus medical therapy].
    Nishigaki K
    Nihon Rinsho; 2011 Feb; 69(2):253-8. PubMed ID: 21387672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
    Sedlis SP; Jurkovitz CT; Hartigan PM; Kolm P; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; Boden WE; Weintraub WS;
    Am J Cardiol; 2013 Dec; 112(11):1703-8. PubMed ID: 24011740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The truth and consequences of the COURAGE trial.
    Kereiakes DJ; Teirstein PS; Sarembock IJ; Holmes DR; Krucoff MW; O'Neill WW; Waksman R; Williams DO; Popma JJ; Buchbinder M; Mehran R; Meredith IT; Moses JW; Stone GW
    J Am Coll Cardiol; 2007 Oct; 50(16):1598-603. PubMed ID: 17936161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
    Katritsis DG; Ioannidis JP
    Circulation; 2005 Jun; 111(22):2906-12. PubMed ID: 15927966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia is the critical determinant of revascularization benefit: an interventionalist's perspective of the COURAGE trial.
    Kereiakes DJ
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S45-52. PubMed ID: 19898281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
    Mancini GB; Bates ER; Maron DJ; Hartigan P; Dada M; Gosselin G; Kostuk W; Sedlis SP; Shaw LJ; Berman DS; Berger PB; Spertus J; Mavromatis K; Knudtson M; Chaitman BR; O'Rourke RA; Weintraub WS; Teo K; Boden WE;
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):320-7. PubMed ID: 20031857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief.
    Wijeysundera HC; Nallamothu BK; Krumholz HM; Tu JV; Ko DT
    Ann Intern Med; 2010 Mar; 152(6):370-9. PubMed ID: 20231568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal medical therapy is a proven option for chronic stable angina.
    O'Rourke RA
    J Am Coll Cardiol; 2008 Sep; 52(11):905-7. PubMed ID: 18772059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Acharjee S; Teo KK; Jacobs AK; Hartigan PM; Barn K; Gosselin G; Tanguay JF; Maron DJ; Kostuk WJ; Chaitman BR; Mancini GB; Spertus JA; Dada MR; Bates ER; Booth DC; Weintraub WS; O'Rourke RA; Boden WE;
    Am Heart J; 2016 Mar; 173():108-17. PubMed ID: 26920603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.